Aytu BioPharma (AYTU) Stock Chart & Stock Price History → Collapse of the Petrodollar (From Colonial Metals) (Ad) Free AYTU Stock Alerts $3.03 -0.16 (-5.02%) (As of 06/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Aytu BioPharma Stock Price Performance5 Day Performance-6.19%1 Month Performance-3.81%3 Month Performance-4.72%6 Month Performance+24.69%Year-To-Date Performance+6.69%1 Year Performance+90.57% Receive AYTU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aytu BioPharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar. For one main reason.In answer to this issue, we have released a Special Report to the public. AYTU Stock Chart for Saturday, June, 8, 2024 AYTU Chart by TradingView Aytu BioPharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$3.19$3.03-5.02%$3.19$3.0247,149 shs$16.88 million06/06/2024$3.20$3.19-0.31%$3.21$3.0720,292 shs$17.77 million06/05/2024$3.18$3.20+0.63%$3.20$3.108,101 shs$17.82 million06/04/2024$3.23$3.18-1.55%$3.21$3.0721,544 shs$17.71 million06/03/2024$3.15$3.23+2.54%$3.23$3.1627,336 shs$17.99 million05/31/2024$3.11$3.15+1.29%$3.19$3.138,329 shs$17.55 million Get the Latest News and Ratings for AYTU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aytu BioPharma and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$3.03$3.11+2.59%$3.18$3.0210,183 shs$17.32 million05/29/2024$3.15$3.03-3.77%$3.19$3.0128,573 shs$16.89 million05/28/2024$3.20$3.15-1.56%$3.23$3.1256,666 shs$17.55 million05/27/2024$3.20$3.20$3.24$3.1523,700 shs$17.82 million05/24/2024$3.20$3.20$3.24$3.1523,740 shs$17.82 million05/23/2024$3.12$3.20+2.56%$3.20$3.0517,638 shs$17.82 million05/22/2024$3.14$3.12-0.64%$3.15$3.0816,802 shs$17.38 million05/21/2024$3.08$3.14+1.95%$3.17$3.024,159 shs$17.49 million05/20/2024$2.94$3.08+4.76%$3.17$2.9823,067 shs$17.16 million05/17/2024$2.96$2.94-0.68%$2.96$2.9021,134 shs$16.38 million05/16/2024$3.06$2.96-3.27%$3.35$2.7540,652 shs$16.49 million05/15/2024$3.32$3.06-7.83%$3.40$3.0645,354 shs$17.04 million05/14/2024$3.31$3.32+0.30%$3.45$3.2422,624 shs$18.49 million05/13/2024$3.27$3.31+1.22%$3.42$3.2359,967 shs$18.44 million05/10/2024$3.18$3.24+1.89%$3.26$3.1715,211 shs$18.04 million05/09/2024$3.15$3.18+0.95%$3.20$3.079,482 shs$17.71 million05/08/2024$3.06$3.15+2.94%$3.18$3.076,093 shs$17.55 million05/07/2024$3.06$3.06$3.11$3.055,914 shs$17.04 million05/06/2024$3.01$3.06+1.66%$3.17$3.0443,531 shs$17.04 million05/03/2024$3.01$3.01$3.04$2.9221,150 shs$16.77 million05/02/2024$2.89$3.01+4.04%$3.01$2.957,349 shs$16.77 million05/01/2024$2.81$2.89+2.96%$2.95$2.857,935 shs$16.12 million04/30/2024$2.81$2.81$2.89$2.812,653 shs$15.65 million04/29/2024$2.90$2.81-3.25%$2.93$2.813,834 shs$15.65 million04/26/2024$2.84$2.82-0.70%$2.92$2.826,134 shs$15.71 million04/25/2024$2.80$2.84+1.43%$2.87$2.717,951 shs$15.82 million04/24/2024$2.71$2.80+3.32%$2.80$2.6313,960 shs$15.60 million04/23/2024$2.78$2.71-2.52%$2.85$2.719,066 shs$15.10 million04/22/2024$2.79$2.78-0.36%$2.88$2.756,642 shs$15.49 million04/19/2024$2.79$2.79$2.83$2.746,921 shs$15.54 million04/18/2024$2.87$2.79-2.90%$2.93$2.793,294 shs$15.54 million04/17/2024$2.92$2.87-1.60%$2.94$2.764,308 shs$16.00 million04/16/2024$2.67$2.92+9.36%$2.92$2.687,382 shs$16.26 million04/15/2024$2.89$2.67-7.61%$2.86$2.6555,660 shs$14.87 millionBill Clinton Backing Biden Replacement??? (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________.04/12/2024$3.12$2.89-7.38%$3.12$2.8426,458 shs$16.10 million04/11/2024$3.26$3.12-4.29%$3.22$3.0826,603 shs$17.37 million04/10/2024$3.36$3.26-2.98%$3.36$3.1513,404 shs$18.15 million04/09/2024$3.30$3.36+1.82%$3.38$3.2713,205 shs$18.72 million04/08/2024$3.22$3.30+2.48%$3.35$3.1040,063 shs$18.38 million04/05/2024$3.20$3.20$3.22$3.0915,837 shs$17.82 million04/04/2024$3.13$3.20+2.24%$3.20$2.9821,840 shs$17.82 million04/03/2024$3.03$3.13+3.30%$3.13$3.0412,003 shs$17.43 million04/02/2024$2.99$3.03+1.34%$3.04$2.9810,254 shs$16.88 million04/01/2024$3.04$2.99-1.64%$3.17$2.9715,656 shs$16.65 million03/29/2024$3.04$3.04$3.12$3.0115,205 shs$16.93 million03/28/2024$3.08$3.04-1.30%$3.12$3.0115,205 shs$16.93 million03/27/2024$3.08$3.08$3.09$2.9113,819 shs$17.16 million03/26/2024$3.07$3.08+0.33%$3.09$3.057,482 shs$17.16 million03/25/2024$3.04$3.07+0.99%$3.17$2.9841,292 shs$17.10 million03/22/2024$2.98$3.04+2.01%$3.11$2.946,165 shs$16.93 million03/21/2024$2.89$2.98+3.11%$3.07$2.8710,038 shs$16.60 million03/20/2024$2.86$2.89+1.05%$2.97$2.8821,331 shs$16.10 million03/19/2024$2.89$2.86-1.04%$2.97$2.8613,205 shs$15.93 million03/18/2024$2.87$2.89+0.70%$3.11$2.8262,253 shs$16.10 million03/15/2024$2.87$2.87$2.96$2.8411,517 shs$15.99 million03/14/2024$3.05$2.87-5.90%$3.14$2.7626,215 shs$15.99 million03/13/2024$3.15$3.05-3.17%$3.22$3.0111,322 shs$16.99 million03/12/2024$3.15$3.15$3.23$3.1222,750 shs$17.55 million03/11/2024$3.14$3.15+0.32%$3.25$3.0617,642 shs$17.54 million03/08/2024$3.09$3.18+2.91%$3.20$3.0924,242 shs$17.71 million03/07/2024$2.99$3.09+3.34%$3.09$3.0122,813 shs$17.21 million Related Companies: BioXcel Therapeutics Stock Price Chart Viveon Health Acquisition Stock Price Chart MediciNova Stock Price Chart Rallybio Stock Price Chart Celularity Stock Price Chart Eledon Pharmaceuticals Stock Price Chart Affimed Stock Price Chart Checkpoint Therapeutics Stock Price Chart Immix Biopharma Stock Price Chart Theratechnologies Stock Price Chart Receive AYTU Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aytu BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AYTU) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredWarren Buffett & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aytu BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aytu BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.